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Abstract: Gluten is composed of prolamin and glutelin proteins from several related grains. Because
these proteins are not present in identical ratios in the various grains and because they have some
differences in sequence, the ability to accurately quantify the overall amount of gluten in various
food matrices to support gluten-free labeling is difficult. Four sandwich ELISAs (the R-Biopharm AG
R5 RIDASCREEN® , the Neogen Veratox® R5, the Romer Labs AgraQuant® G12, and the Morinaga
Wheat kits) were evaluated for their performance to quantify gluten concentrations in various foods
and ingredients. The Morinaga and AgraQuant® G12 tests yielded results comparable to the two R5
kits for most, but not for certain, foods. The results obtained with the Morinaga kit were lower when
compared to the other kits for analyzing powders of buckwheat and several grass-based products.
All four kits were capable of detecting multiple gluten-containing grain sources including wheat, rye,
barley, semolina, triticale, spelt, emmer, einkorn, Kamut™, and club wheat. Users of the ELISA kits
should verify the performance in their hands, with matrices that are typical for their specific uses.
The variation in results for some food matrices between test methods could result in trade disputes
or regulatory disagreements.
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1. Introduction
Two major types of adverse immunological reactions occur from ingestion of glutencontaining grains (wheat, barley, rye, and related grains) among susceptible consumers:
cell-mediated reactions and immunoglobulin E (IgE)-mediated allergic reactions [1]. Certain
proteins in these grains are responsible for both types of reactions. These grains contain
multiple proteins that are classified into several categories: albumins, globulins, prolamins,
and larger prolamin-like glutelins. The latter two types form viscoelastic masses when
mixed and kneaded with water.
The prolamins and glutelins are associated with provocation of celiac disease (CeD),
dermatitis herptiformis (DH), and non-celiac gluten sensitivities (NCGSs) [1]. CeD is estimated to affect nearly 1% of the U.S. population [2]. NCGSs affect an unknown but possibly
larger percentage [3]. CeD is a T-cell mediated response to digestion-resistant gluten peptides [4]. CeD is a delayed hypersensitivity reaction with symptoms typically occurring
48–72 h after acute exposures to gluten. Native gluten peptides and those deamidated by
the consumer’s endogenous tissue transglutaminase mediate the enteropathy [5]. CeD and
DH are provoked by all of the gluten-containing grains (wheat, rye, and barley) except oats
that are tolerated by the vast majority of individuals with CeD if pure and uncontaminated
with the other gluten-containing grains [6]. Individuals with NCGS experience intestinal
symptoms on ingestion of gluten but do not display the intestinal inflammatory damage
that is characteristic of untreated CeD [3]. The mechanism of NCGS has not yet been
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elucidated. CeD, DH, and NCGS are managed with gluten avoidance diets in part through
the consumption of gluten-free (GF) foods.
All of the gluten-containing grains can cause IgE-mediated, immediate hypersensitivity reactions [7]. Unlike CeD, cross reactions do not occur among the various glutencontaining grains for most affected individuals. Wheat allergy is, by far, the most prevalent
of the allergies to the various gluten-containing grains affecting <1% of the U.S. population [8–10]. Higher prevalence was reported in Thailand, South Korea, and Japan, where
rice is the staple cereal [11–13]. Some individuals with wheat allergy experience reactions only when they exercise concomitantly with ingestion of wheat, a condition known
as wheat-dependent, exercise-induced anaphylaxis (WDEIA) [7]. Individuals with IgEmediated allergies to one of the gluten-containing grains must only avoid that single grain
and any protein-containing ingredients derived from it. However, for practical reasons,
these consumers also likely rely, in part, on gluten-free products in their avoidance strategy.
To protect consumers with food allergies and intolerances, the Codex Alimentarius
Commission established guidance that required the declaration of certain foods or ingredients derived therefrom on food package labels in 1999 [14]. That priority list included
cereal sources of gluten, defined a protein from wheat, rye, and barley. Most countries
subsequently enacted regulations requiring the labeling of cereal sources of gluten. However, in the USA, wheat was recognized for its role in IgE-mediated food allergies and a
regulation was established to require source labeling of wheat and any ingredients derived
therefrom on packaged food labels [15]. Barley, rye, and other gluten-containing grains and
their ingredients were not included in this regulation.
Subsequently, the Codex Alimentarius Commission proposed a global Standard for
Foods for Special Dietary Use for a Person Intolerant to Gluten in 2008 [16]. According
to this standard, a food product would be considered gluten-free only if the final gluten
level in the product is determined to be less than 20 ppm gluten, defined as those proteins,
commonly found in wheat, triticale, rye, barley, or oats to which some consumers are
intolerant. Many countries, including the U.S., have developed regulations for gluten-free
labeling that comply with the recommended level of 20 ppm gluten. However, some
countries have also allowed the marketing of oats as gluten-free if residual gluten levels
are <20 ppm [17].
The global implementation of gluten-free labeling regulations requires the use of
methods for the detection of gluten residues from wheat, rye, barley, and related grains
at a level of sensitivity below 20 ppm gluten. To assure compliance with gluten-free
labeling regulations and to protect sensitive consumers, the food industry must ensure
the absence of gluten (down to <20 ppm) by careful formulation, control of ingredient
sources, segregation of the manufacture of gluten-containing foods, and application of
accurate labeling. The success of gluten-free labeling relies on the accuracy and limitations
of the analytical methods used to detect gluten residues. Multiple, quantitative commercial
methods, primarily enzyme-linked immunosorbent assays (ELISAs), are available for the
detection of gluten residues in foods [18–20]. ELISA-based methods are relatively simple,
fast, and have become the most widely used gluten detection methods. ELISA-based
methods have been reported to be reliable in detecting gluten at the level of 20 ppm in a
variety of types and forms of food [21]. However, only one of these ELISA methods, the
R5 Méndez method has been recognized as a Type I method (defining method) for gluten
analysis, an AOAC Official MethodSM [22]. In general, it is permissible to use equivalent
methods for the detection of gluten residues. The U.S. FDA regulation does not specify any
specific analytical methods for compliance testing but recommends that food manufacturers
may choose any scientifically valid method that is most appropriate to reliably detect the
presence of 20 ppm gluten in their products [23]. However, limited data exist on the
equivalency of results obtained by the various commercial gluten ELISAs across a range
of relevant food matrices and at low residue levels around the 20-ppm limit. The existing
commercial gluten ELISA kits have variations in format, antibody, specificity, sensitivity,
and extraction buffers and different results were observed in many food samples [24,25].
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The consequences of any variability in results by use of different methods of analysis are
obvious in terms of buyer-seller expectations and regulatory compliance.
As the choice of analytical method is crucial to ensuring consumer safety, the objective
of this study was to compare the suitability and performance of four commercial sandwich
ELISA kits to confirm the gluten-free status of foods and ingredients. Gluten analysis
was performed on 32 foods and ingredients representing various matrices and focusing
primarily on samples that had low levels of gluten residues surrounding the 20-ppm
target level for gluten-free status. Additionally, the ability of these same four commercial
sandwich ELISAs to detect gluten residues from a wide range of gluten-containing and
other grains was evaluated.
2. Materials and Methods
2.1. Commercial Sandwich ELISA Kits and Reagents
The kits used were the RIDASCREEN® Gliadin kit (R-Biopharm AG, Darmstadt,
Germany; Art. No. R7001; the AOAC-RI license #120601, the AOAC-OMA license #2012.01,
and the AACC International Approved Method 38–50.01), the Veratox® for Gliadin R5
kit (Neogen Corporation, Lansing, MI, USA; Product No. 8510; the AOAC-RI license#
061201), the Wheat Protein ELISA kit (Gliadin) (Morinaga Institute of Biological Science,
Inc., Yokohama, Japan; Cat. No. 181GD), and the AgraQuant® Gluten G12 assay (Romer
Labs UK Ltd., Cheshire, UK; Product No. COKAL0200; the AOAC-OMA license #2014.03
and the AACC International Approved Method 38–52.01). The Neogen gliadin renaturing
cocktail solution was purchased from Neogen Corporation (Lansing, MI, USA). Ethanol
was purchased from EMD Chemicals Inc. (Gibbstown, NJ, USA). Beta-mercaptoethanol was
purchased from Sigma Aldrich (St. Louis, MO, USA). Skim milk powder was purchased
from Oxoid Ltd. (Basingstoke, Hampshire, UK). The testing of samples with each kit was
performed according to the manufacturer’s instructions. The absorbance values were read
using a Spectra MRTM Microplate Spectrophotometer (DYNEX Technologies, Inc., Chantilly,
VA, USA). Samples with absorbance values over the highest standard were diluted further
and re-tested until the values fell within the range of standards. The parameters used in
each kit are summarized in Table 1.
2.2. The 32 Food and Ingredient Samples
Since our laboratory has analyzed a number of foods and ingredients for the food
industry and CeD support organizations for many years, we selected a set of 32 samples
(Table 2) to represent a wide range of grains and gluten concentrations and to encompass a
wide range of food matrices. All the samples had previously tested at levels of between
5–1000 ppm gluten by the RIDASCREEN® Gliadin kit or the RIDASCREEN® FAST Gliadin
kit, except for the raw meat sample which was previously tested to contain more than
1000 ppm gluten but was chosen to include a meat matrix. Samples were processed to
provide a relatively uniform distribution of sample material prior to extraction. Raw meat
was blended using a Cuisinart Mini-Prep Plus® processor (Model DLC-2A). Cereal bars,
chips, and cookies were milled using a commercial blender (Osterizer® , Boca Raton, FL,
USA). Two subsamples were analyzed in duplicate using the R-Biopharm AG, the Neogen,
and the Morinaga kits. Three subsamples were analyzed in duplicate with the Romer
Labs kit.
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Table 1. Parameters of the four commercial sandwich ELISA kits used in the study.
R-Biopharm AG:
RIDASCREEN®
Gliadin Kit

Neogen: Veratox® for
Gliadin R5 Kit

Romer Labs:
AgraQuant® Gluten
G12 Assay

Morinaga: Wheat
Protein ELISA Kit
(Gliadin)

mAb R5 (reported to
recognize QQPFP,
QQQFP, LQPFP, QLPFP,
QLPYP, QLPTF, QQSFP,
QQTFP, QQPYP,
PQPFP, QQPFPQ,
QQPFPL, PQQPFP,
SQQPFP, QLPFPQ,
QRPFAQ, QQSFPQ,
and QXPW/FP) [26–28]
Gliadin

mAb G12 (reported to
recognize QPQLPY,
QPQLPF, QPQLPL,
QPQQPY, and
QPELPY) [19]

pAb (gliadin as a
marker for wheat
protein)

Calibration Standard
(Analytical Target)

mAb R5 (reported to
recognize QQPFP,
QQQFP, LQPFP, QLPFP,
QLPYP, QLPTF, QQSFP,
QQTFP, QQPYP,
PQPFP, QQPFPQ,
QQPFPL, PQQPFP,
SQQPFP, QLPFPQ,
QRPFAQ, QQSFPQ,
and QXPW/FP) [26–28]
Gliadin (the PWG
gliadin)

Gliadin (the PWG
gliadin)

Detection Limit
Limit of Quantification

3 ppm gluten
5–80 ppm gluten

5 ppm gluten
5–80 ppm gluten

2 ppm gluten
4–200 ppm gluten

Protein Extraction

Extracted * with the
Cocktail (patented)
solution (Cat# R7006)
(containing 250 mM
β-mercaptoethanol, 2M
guanidine
hydrochloride, and
0.1X PBS) at 50 ◦ C for
40 min followed by 80%
ethanol at 25 ◦ C for 60
min, centrifuged, and
diluted with the sample
diluent.

For non-heat processed
samples, extracted with
60% ethanol plus the
provided extraction
additive for 10 min,
centrifuged, and
diluted with the
provided PBS.

Extracted * with the
provided extraction
solution (containing
<1%
β-mercaptoethanol,
19% guanidine
hydrochloride, and
<1% PBS) at 50 ◦ C for
40 min followed by 80%
ethanol at 25 ◦ C for 60
min, centrifuged, and
diluted with the
provided dilution
buffer.

Wheat protein (gliadin
as a marker for wheat
protein)
0.3 ppm wheat protein
0.3–20 ppm wheat
protein
Extracted with
provided extraction
buffer containing
β-mercaptoethanol at
25 ◦ C for 12 hr,
adjusted pH to neutral,
centrifuged, and
diluted with the
provided diluents.

Sandwich ELISA Kit
Antibody

* Equal amount of
skimmed milk is added in
tannin and polyphenol
containing samples (e.g.
cocoa, buckwheat, and
spices). Meat sample was
homogenized prior to
extraction as
recommended in the
instruction

Result Interpretation

Gluten content is
calculated by the
software RIDA® SOFT
Win (Art. No. Z9999)
using cubic spline
model. Gluten content
is conversed from
gliadin content by a
factor of 2.

For heat-processed or
unknown commodities,
extracted * with the
gliadin renaturing
cocktail solution (Cat#
8515) (containing 19%
guanidine
hydrochloride) at 50 ◦ C
for 40 min followed by
80% ethanol at 25 ◦ C
for 60 min, centrifuged,
and diluted with the
provided PBS.
* Sample containing
tannin/phenolic
compounds (e.g., cocoa
and buckwheat) is added
with the provided
extraction additive.
Calculated by the
Veratox 3.0.1 software
using log/logit model.
Gluten content is
conversed from gliadin
content by a factor of 2.

* For chocolate containing
sample, equal amount of
powdered fish gelatin is
added.

Calculated by the
provided Romer Labs®
spreadsheet using
linear model.

Calculated by the
GraphPad Prism® 403
software (GraphPad
Prism® software, Inc.,
San Diego, CA, USA)
using linear model.
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Table 2. Analysis of gluten/wheat protein in foods and ingredients by the four commercial sandwich ELISA kits.
R-Biopharm AG
RIDASCREEN®
Gliadin Kit (n = 2)

Sample

Gluten ± SD, ppm
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Ground raw meat
Organic oat flakes
Corn flour
Brown rice syrup
Navy bean flour
Red lentil flour
Cereal powder
Wheat starch powder
Malt drink
Nutty rice bar
Ground rice crisp
Green pea flour
Gluten free oats flour
Sorghum powder
Organic wheat grass juice powder
Resistant wheat starch
Barley grass juice powder
Resistant wheat starch
Seasoning powder
Oat flour
Sugar babies cookie **
Yeast extract powder
Tortilla chips
Hemp protein powder
Cookie
Cocoa powder
Bar flavor
Organic Alfalfa grass juice powder
White rice flour

± 310
± 41.9
± 24.2
± 9.50
± 3.50
± 9.57
± 2.72
± 0.06
± 0.69
± 2.12
± 0.44
± 1.59
± 6.15
± 15.7
± 0.11
± 1.52
± 2.31
± 0.26
± 0.12
BLQs
BLQs
891 ± 83.8
494 ± 53.5
466 ± 133
277 ± 3.31
229 ± 71.6
152 ± 2.63
121 ± 6.49
92.0 ± 4.39

1690
158
185
131
86.8
73.6
69.4
41.0
19.4
16.3
14.0
13.7
10.7
36.7
18.9
8.19
7.47
6.41
5.73

a
a
a
a
a, b
a
a
a, b
a, b
b
a
a
a
a
b
b
a
a
a

a, b
b
a
a
a
a
a
a

Neogen Veratox®
for Gliadin R5 Kit (n = 2)
%CV
18.3
26.5
13.1
7.2
4.0
13.0
3.9
0.1
3.5
13.0
3.1
11.6
57.3
42.7
0.6
18.6
30.9
4.1
2.1

9.4
10.8
28.5
1.2
31.2
1.7
5.3
4.8

Gluten ± SD, ppm
1694 ± 451
173 ± 118
154 ± 28.4
92.7 ± 9.48
110 ± 14.4
63.8 ± 5.59
46.7 ± 8.49
21.8 ± 5.23
25.4 ± 2.79
16.1 ± 1.10
15.4 ± 0.25
15.8 ± 0.39
14.1 ± 4.14
7 and BLQ
26.1 ± 0.07
6.8 and BLQ
5.15 ± 0.64
BLQs
BLQs
BLQs
BLQs
1539 ± 818
468 ± 104
433 ± 92.0
226 ± 20.4
207 ± 5.66
134 ± 18.8
67.7 ± 2.47
79.5 ± 27.5

a
a
a, b
b
a
a, b
a, b
b
a
b
a
a
a
a
a
b
a

a
b
a
a
a, b
a
b
a, b

%CV
1.7
68.5
18.4
10.2
13.1
8.8
18.2
24.0
11.0
6.8
1.6
2.5
29.3
35.9
12.4

53.2
22.2
21.3
9.0
23.6
14.0
3.7
34.6

Romer Labs AgraQuant®
G12 Assay (n = 3)
Gluten ± SD, ppm
1762 ± 90.7
72.1 ± 7.96
118 ± 24.5
128 ± 15.1
65.5 ± 18.2
49.8 ± 6.97
69.6 ± 15.9
19.9 ± 3.55
17.0 ± 0.94
11.1 ± 1.48
9.00 ± 1.01
11.4 ± 2.58
9.25 ± 6.96
3.63 and BLQs
6.80 ± 1.23
5.76 ± 0.90
BLQs
BLQs
BLQs
18.6 ± 3.54
BLQs
176 ± 28.5
650 ± 24.9
104 ± 25.3
149 ± 31.3
142 ± 6.30
64.6 ± 9.60
80.2 ± 6.02
106 ± 24.0

a
a
b
a
b
b
a
b
b
c
b
a
a
a
c
b

%CV
5.1
11.0
20.8
11.8
27.8
14.0
22.8
17.8
5.5
13.4
11.2
22.7
75.2
18.1
15.6

a

19.0

b
a, b
b
b
b
b
b
a

16.2
3.8
24.2
21.0
4.4
14.9
7.5
22.7

Morinaga Wheat Protein
ELISA Kit (n = 2)
Wheat Protein ± SD, ppm
1972 ± 488
119 ± 70.1
204 ± 34.5
63.9 ± 17.6
70.6 ± 8.33
47.5 ± 6.19
30.1 ± 7.06
53.0 ± 19.1
17.9 ± 5.43
22.7 ± 0.95
12.5 ± 3.75
16.7 ± 7.22
12.4 ± 0.88
7.67 ± 2.96
1.29 and BLQ
14.9 ± 0.00
BLQs
7.87 ± 6.30
6.57 ± 0.37
8.23 and BLQ
BLQs
500 ± 211
1000 ± 233
97.3 ± 31.7
83.7 ± 32.1
134 ± 36
45.9 ± 0.60
BLQs
35.8 ± 9.22

%CV

a
a
a
b
b
b
b
a
b
a
a, b
a
a
a
d
a

24.7
58.9
16.9
27.5
11.8
54.3
23.5
36.0
30.4
4.2
30.1
43.1
7.1
38.6

a
a
a

80.1
5.6

b
a
b
c
b
b

42.3
23.3
32.5
38.4
27.1
1.3

b

25.7

0.0
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Table 2. Cont.
R-Biopharm AG
RIDASCREEN®
Gliadin Kit (n = 2)

Sample

30
31
32

Organic Kamut grass juice powder
Barley grass juice powder
Organic creamy buckwheat powder

Neogen Veratox®
for Gliadin R5 Kit (n = 2)

Gluten ± SD, ppm

%CV

± 3.22
± 9.34
± 18.7

4.1
14.3
59.2

78.9
65.5
31.6

a
a
a

Gluten ± SD, ppm
67.1
43.2
26.5

± 19.3
± 5.23
± 21.1

a
b
a

%CV
28.7
12.1
79.5

Romer Labs AgraQuant®
G12 Assay (n = 3)
Gluten ± SD, ppm
59.8
62.6
20.9

± 1.92
± 9.17
± 9.12

a
a
a

%CV
3.2
14.6
43.5

Morinaga Wheat Protein
ELISA Kit (n = 2)
Wheat Protein ± SD, ppm
6.94 and BLQ
6.11 ± 2.08
2.08 ± 1.34

b
c
a

%CV
34.1
64.4

Values within each row followed by different letters are significantly different (α = 0.05). BLQ = below limit of quantification. ** Sugar babies cookie originally tested in R-Biopharm AG
RIDASCREEN® Gliadin assay at 10 ppm. Failure to detect gluten residues by any method in this comparative analysis is likely attributable to subsampling differences or perhaps a
laboratory error in the initial analysis.
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2.3. Preparation and Analyses of Cereal Grain Spiked Samples
Sixteen powders of wheat, barley, rye, triticale, oat, and sorghum were used in the
spike-and-recovery experiments (Table 3). The following samples were purchased from
local stores in Lincoln, NE: C&H® pure cane granulated white sugar; organic whole grain
barley flour (Arrowhead Mills, Inc., Hereford, TX, USA); organic whole grain rye flour
(Arrowhead Mills, Inc.); semolina wheat flour (General Mills Corp., LLC, Minneapolis,
MN, USA); 100% stone ground whole (hard red spring) common wheat flour (Bob’s Red
Mill, Milwaukie, OR, USA); and gluten-free, stone ground white rice flour (Bob’s Red Mill).
Kiln roasted whole grain oat flour and kiln roasted rolled oats (both labeled gluten-free
and wheat-free) were purchased from Château CREAM HILL Estates (LaSalle, Québec,
Canada). Organic whole Durum wheat flour was purchased from Barry Farm Foods
(Wapakoneta, OH, USA). Whole emmer wheat grains were purchased from Bluebird Grain
Farms (Winthrop, WA, USA). Einkorn wheat kernels were purchased from InfraReady
Products (1998) Ltd. (Saskatoon, Saskatchewan, Canada). Whole grains of club wheat were
provided by Dr. David Jackson (Nebraska Agricultural Experiment Station). Whole grains
of sorghum (Sorghum bicolor var. Macia) and two varieties of oat (Avena sativa var. Jerry
and var. Ogle) grown in fields separated from wheat, barley, rye, and triticale to prevent
cross-contamination were provided by the Department of Agronomy and Horticulture and
Husker Genetics (University of Nebraska Agricultural Research Division), respectively.
Whole grains of Kamut™ (Khorasan) wheat, spelt, and triticale were provided by Dr. James
Glueck (Arrowhead Mills, Inc.). Crude wheat gluten was purchased from Sigma Aldrich
(St. Louis, MO, USA; Cat # G5004-500G; Lot# SLBB0512V).
Prior to the spiking, the protein content of the 17 grains and flours was analyzed in
triplicate subsamplings by the Dumas method (Table 3). The sugar, grains, and kernels
were milled and homogenized to uniformity using a SPEX CertiPrep Freezer/Mill 6850
for three cycles (each for 2 min). For the powders of sorghum and oats, three subsamples
were directly analyzed in duplicate by each of the four kits. Since the wheats, barley, rye,
triticale, and crude wheat gluten are high in gluten proteins, we spiked each powder of the
grains and crude wheat gluten into ground sugar since the sugar contained no detectable
gluten or wheat protein by any of the four kits and was previously demonstrated to
provide no interference with gluten analysis. The spiking is designed to represent possible
contamination scenarios. For the crude wheat gluten, 100 mg powder was spiked into 99.9 g
ground sugar to provide a sample of about 1000 ppm gluten. We also spiked the crude
wheat gluten into each of the powders of sorghum and oats. Since gluten proteins account
for nearly 80% of the protein in common wheat and barley [29], 1.116 g of each of the grain
flour were spiked into 98.88 g of ground sugar to provide samples of around 1000 ppm
gluten. To normalize the weight ratio, the other grain flours were spiked similarly. Spiking
was conducted in a KitchenAid blade coffee grinder (model BCG100WH) for 2 min. Three
independent spiking replicates were prepared for each of the grains. To assess the spiking
homogeneity, four subsamples from each of the three independent spiking replications of
each grain were analyzed in duplicate by the R-Biopharm AG kit. One subsample was
analyzed in duplicate by the Neogen, the Morinaga, and the Romer Labs kits.
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Table 3. Analysis of gluten/wheat protein in cereal grains by the four commercial sandwich ELISA kits.

Grain Sample

Protein Content
Measured by the
Dumas Method (n = 3)
Protein ± SD, ppm

Rye, Triticale, and Barley
Organic whole grain rye flour (S. cereale)
Whole Triticale grains (× Triticosecale)
Organic whole grain barley flour (H.
vugalre)
Hexaploid wheat
Whole spelt grains (T. aestivum L. subsp.
spelta (L.) Thell.)
Stone ground whole (hard red spring)
common wheat flour (T. aestivum L. subsp.
Aestivum)
Whole club wheat grains (T. aestivum L.
subsp. compactum (Host) Mackey)
Tetraploid wheat
Whole Emmer wheat grains (T. turgidum
L. subsp. dicoccum (Schrank ex Schübl.)
Thell)
Semolina wheat flour (T. turgidum L.
subsp. durum (Desf.) Husn.)
Organic whole Durum wheat flour (T.
turgidum L. subsp. durum (Desf.) Husn.)
Whole KamutTM (Khorasan) grains (T.
turgidum L. subsp. turanicum (Jakubz.) Á.
& D. Löve)
Diploid wheat
Einkorn wheat kernels (T. monococcum L.
subsp. Monococcum)
Oat and Sorghum
Whole oat grains (A. sativa var. Ogle)
Whole oat grains (A. sativa var. Jerry)
Kiln roasted rolled oats (A. sativa)
Kiln roasted whole grain oat flour (A.
sativa)
Whole sorghum grains (S. bicolor var.
Macia)

R-Biopharm AG
RIDASCREEN® Gliadin Kit
(n = 3)
Gluten ± SD, ppm

Neogen Veratox® for Gliadin
R5 Kit (n = 3)

%CV

Gluten ± SD, ppm

Romer Labs AgraQuant® Gluten
G12 Assay (n = 3)

%CV

Gluten ± SD, ppm

%CV

Morinaga Wheat Protein ELISA
Kit (Gliadin) (n = 3)
Wheat Protein ± SD, ppm

%CV

96,300
142,900

±
±

1600
3800

3271
2619

±
±

1448
1620

a
a

44.3
61.9

523
526

±
±

71.3
133

d
b

13.6
25.4

811
834

±
±

94.0
222

c
b

11.6
26.6

1216
1446

±
±

48.9
145

b
a, b

4.0
10.0

36,300

±

1500

2188

±

775

a

35.4

577

±

253

b

43.9

2023

±

356

a

17.6

801

±

129

b

16.1

100,700

±

900

1785

±

858

a

48.1

629

±

193

a

30.6

737

±

21.7

a

2.9

781

±

71.0

a

9.1

146,300

±

1400

1224

±

547

a, b

44.7

447

±

161

c

36.1

1180

±

171

b

14.5

1513

±

67.1

a

4.4

79,700

±

1800

388.7

±

44.9

a

11.5

147

±

15.3

c

10.5

243

±

95.1

b, c

39.2

356

±

57.5

a, b

16.2

126,000

±

1600

464.3

±

27.4

b

5.9

157

±

34.0

c

21.7

219

±

59.6

c

27.3

676

±

90.0

a

13.3

130,800

±

200

417.4

±

73.0

b

17.5

236

±

21.2

c

9.0

207

±

79.3

c

38.2

1031

±

196

a

19.0

180,600

±

86,100

414.6

±

94.2

b

22.7

172

±

20.3

c

11.8

241

±

72.6

c

30.1

1179

±

75.7

a

6.4

160,800

±

1000

271.0

±

59.4

b

21.9

95.1

±

44.6

c

46.9

256

±

20.5

b

8.0

1019

±

97.2

a

9.5

143,100

±

2800

131.1

±

16.9

b

12.9

163

±

33.0

b

20.2

97.8

±

7.86

c

8.0

485

±

83.4

a

17.2

145,700
163,500
147,900

±
±
±

5000
5000
1500

BLQs
BLQs
BLQs

BLQs
BLQs
BLQs

15.4
15.4
14.3

±
±
±

1.72
1.55
2.69

a
a

11.2
10.1
18.8

5.02
2.79

BLQs
± 7.38
± 0.78

a
a

147.0
28.0

116,600

±

3000

BLQs

BLQs

12.6

±

4.29

34.2

0.32 and BLQs

98,400

±

2300

BLQs

BLQs

7.02

±

3.03

43.1

BLQs
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Table 3. Cont.
Protein Content
Measured by the
Dumas Method (n = 3)

Grain Sample

Protein ± SD, ppm
Spiked 1000 ppm crude wheat gluten
In ground cane sugar
In whole oat grain powder (A. sativa var.
Ogle)
In whole oat grain powder (A. sativa var.
Jerry)
In kiln roasted rolled oat powder (A.
sativa)
In kiln roasted whole grain oat flour
In whole sorghum grain powder (S.
bicolor var. Macia)

Gluten ± SD, ppm

Neogen Veratox® for Gliadin
R5 Kit (n = 3)

%CV

Gluten ± SD, ppm

Romer Labs AgraQuant® Gluten
G12 Assay (n = 3)

%CV

Gluten ± SD, ppm

%CV

Morinaga Wheat Protein ELISA
Kit (Gliadin) (n = 3)
Wheat Protein ± SD, ppm

%CV

1477

±

570

a

38.6

480

±

31.4

c

6.5

666

±

112

b

16.8

1151

±

160

a

13.9

Not tested

601

±

109

a, b

18.2

518

±

188

a, b

36.3

467

±

32.9

b

7.0

757

±

115

a

15.2

Not tested

521

±

52.4

a, b

10.1

526

±

69.5

a, b

13.2

455

±

38.7

b

8.5

577

±

45.1

a

7.8

Not tested

421

±

91.1

b

21.6

654

±

137

a

21.0

318

±

21.1

b

6.6

628

±

28.8

a

4.6

798,000

±

R-Biopharm AG
RIDASCREEN® Gliadin Kit
(n = 3)

3400

Not tested

876

±

94.8

a

10.8

607

±

64.1

b

10.5

567

±

18.2

b

3.2

937

±

136

a

14.5

Not tested

67.5

±

12.6

c

18.6

653

±

47.7

a

7.3

247

±

9.40

b

3.8

8.55

±

0.47

d

5.5

Values within each row followed by different letters are significantly different (α = 0.05). BLQ = below limit of quantification.
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2.4. Statistical Analysis
For the 32 foods and ingredients, the grain samples, and the grain spiked sugar/oats/
sorghum samples, the results were analyzed by one-way ANOVA or t-test. Multiple
comparisons were conducted using Fisher’s LSD test and t-test mean comparisons were
performed using a significance level of 0.05 using the SAS® 9.3 software package. The
results below the limit of quantification (BLQ) were excluded from the statistical comparisons.
3. Results and Discussion
For those with adverse reactions to gluten or any of the specific gluten-containing
grains, strict life-long avoidance can be burdensome and difficult since the grains and
their derivatives are widely incorporated in various ingredients and foods. In many food
products, the presence of proteins from these sources is not obvious and consumers must
rely on accurate labeling to avoid exposure. Gluten-free labeling implementation depends
on the accuracy and limitations of the analytical methods used to quantify the gluten
content. Commercial ELISA kits are utilized by many food companies to comply with the
gluten-free labeling regulations.
3.1. The Gluten and Wheat Proteins Contents of the 32 Food and Ingredient Samples
First, the performances of four commercial ELISA kits were evaluated using 32 foods
and ingredients (Table 2). While the source and form of the detectable gluten in these
samples are unknown, they represent real food industry samples including many that had
detectable gluten on initial analysis in low range (5–50 ppm) that might create issues if
different analytical methods yielded variable results. The two R5 kits yielded similar results
for most products as expected. The G12 kit and the Morinaga kit, though reporting result
as wheat protein, not gluten, also yielded similar results to the two R5 kits for most samples
but yielded substantially different results for a few samples including samples #22 (yeast
extract), #24 (hemp protein powder), #25 (cookie), and #27 (bar flavor). Those differences
could be caused by any one of the several reasons: (a) differences in the grain source of
glutens and related proteins, (b) differences in the efficiency of extraction and detection,
(c) subsampling differences with particulates, or (d) some combination. Moreover, though
it is widely agreed that the effect of the food matrix on the detection can be reduced by
dilution, it is impossible for the end user, to elucidate and to exclude the food matrix effect.
Gluten proteins are diverse in character and content, and differences exist in the abundance
of certain antibody-binding epitopes in varieties of wheat, barley, and rye compared to
the mass of total grain or of total protein from these grains [30]. Since the source of the
grain is not known for these 32 samples, it is impossible to ascribe the differences in
results to the identity of the grain or to differentiate possible subsampling differences.
Although we attempted to homogenize the samples thoroughly, there were apparent
subsampling differences based on the high variation (large standard deviation (SD)) in
results for replicate samples using the same assay kit in a few cases (e.g., #1 ground raw
meat, #2 organic oat flakes, #22 yeast extract powder, #23 tortilla chips, #24 hemp protein
powder, and #26 cocoa powder). Most of the variability in results were seen in samples
where particulate contamination might be expected. There are cases where divergent,
though not statistically different, results were obtained with the four kits. For sample
#32 organic creamy buckwheat powder, the results with the four kits were: Morinaga kit,
1.14 ppm and 3.03 ppm; R-Biopharm AG kit, 44.9 ppm and 18.4 ppm; Neogen kit, 41.4 ppm
and 11.6 ppm; and Romer Labs kit, 27.4, 24.9, and 10.5 ppm. The divergent results between
the four kits could be attributed to the variances obtained within each kit and to the small
number of samples (n = 2 and n = 3). The divergence within replicates conducted with
the same kit could also be attributed to variances obtained within each kit but are more
likely due to subsampling differences and to the small sample sizes that are insufficient
for homogeneous subsampling, as previously observed by Fritz and Chen [31]. We do
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not know the true values expected for these samples because they were submitted from
industry sources.
When analyzed with the Morinaga kit, the grass-based samples and especially the #28
organic Alfalfa grass juice powder and the #30 organic KamutTM grass juice powder yielded
apparently lower results than the other kits. Those differences might reflect differences
in the gluten and gluten-like proteins present in the grass-based products and that the
epitopes targeted by the polyclonal antibodies in the Morinaga kit differ from those of
the R5 and G12 monoclonal antibodies. Nevertheless, those cases demonstrated scenarios
when the Morinaga kit cannot successfully confirm the results obtained by the R5 and
G12 kits as previously observed by Scherf [32]. At least three food products (#28, #30, and
#31) verified as gluten-free (<20 ppm) by the Morinaga kit could not be confirmed by the
R5 and G12 kits. Although the exact gluten contents of these products are not confirmed,
underestimation would pose a risk of clinical relapse while an overestimation could result
in unnecessary product rejection or recalls. We note that the Morinaga kit uses a distinct
extraction and calibration scheme. The kit is calibrated in units of wheat protein rather than
gliadin, although it is stated in the instructions that “gliadin is used as a marker for wheat
protein” (Table 1). The factor for converting gliadin into wheat protein for this kit is not
defined. The nature of the immunogen (gliadin from one grain, mixture of gliadins, etc.,)
used to sensitize animals to produce the polyclonal antibodies for the Morinaga kit is not
known. Each of the R5 platforms uses a “gliadin” standard and employs the R5 Méndez
monoclonal antibody that binds to similar native peptides on several prolamins from wheat,
barley, rye, and triticale (Table 1). The R5 kit instructions call for multiplying the calculated
gliadin results by a factor of 2 to estimate the gluten content of a sample. The Romer
Labs platform utilizes a monoclonal antibody that is known to target five native peptides
(Table 1) found in various prolamins and a gluten standard calibrated to the Prolamin
Working Group (PWG) gliadin [33]. Because of the uncertainty about the consistency of
standards between these kits and the specificity of the antibodies used in the kits, one might
expect some differences in detection efficiency between samples. Similar to our observation,
Sharma et al. [24] reported that the R-Biopharm AG and the Morinaga ELISA kits yielded
different results in a number of food products, especially breakfast cereals and bars.
Several samples with rather low detectable levels of gluten in the R-Biopharm AG kit
gave apparent BLQ results in one or more of the other kits but we note that the levels of
gluten in these cases are at or below 20 ppm by all kits except for five samples. First, sample
#9 (malt drink), tested at 19.9 ppm and 18.9 ppm by the R-Biopharm AG kit, at 23.4 ppm and
27.4 ppm by the Neogen kit, at 17.6 ppm, 17.4 ppm, and 15.9 ppm by the Romer Labs kit, and
at 21.7 ppm and 14.0 ppm by the Morinaga kit. Although relatively consistent, the results
demonstrate the difficulty of testing to a fixed limit using sampling and detection methods
that are reproducible, but not identical. Moreover, the case illustrates the complexity in
detecting residual, immunogenic glutens since malting involves enzymatic hydrolysis
of starches and seed storage proteins in barley grains. The sandwich ELISA kits are not
appropriate for quantifying hydrolyzed glutens. Despite having quantified below 20 ppm
by the R-Biopharm AG and Romer Labs kits, this barley-derived product can be labeled
gluten-free only if adequate information regarding the gluten reduction process to meet
the requirement is provided. Second, sample #10 (nutty rice bar), tested at 23.4 ppm and
22.1 ppm by the Morinaga kit while the results from the three other kits tested below
20 ppm. Third, sample #14 (sorghum powder), the R-Biopharm AG kit tested at 47.7 ppm
and 25.6 ppm while results with the other three kits yielded <10 ppm gluten and BLQ
for several replicates. Fourth, sample #15 (organic wheat grass juice powder), tested at
26 ppm and 26.1 ppm by the Neogen kit and at 19 ppm and 18.8 ppm by the R-Biopharm
AG kit whereas the results with the Morinaga and Romer Labs kits were <10 ppm. Fifth,
sample #20 (oat flour), tested at 16.1 ppm and 21.1 ppm by the G12 kit while the other
kits tested at <10 ppm, indicating less likelihood of gluten contamination from Triticeae
sources. This is, however, as expected since the G12 kit is known to react with certain
varieties of oat [34,35]. Nevertheless, these results do not reflect poorly upon the use
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of the R5, G12 or Morinaga methods to support the proposed limit of less than 20 ppm
as gluten-free. In most cases, the four kits provided reasonably consistent results and
they can be used to ensure labeling of foods as gluten-free at a level of certainty that
would protect CeD consumers. However, the five exceptions described above suggest
that to confidently make a gluten-free label claim, the food industry should set a target
gluten level well below 20 ppm since different ELISA kits could yield variable results
around that critical regulatory level. The potential effects of subsampling differences also
indicate the need for conservatism in the establishment of industry target levels. However,
there should be additional consideration and testing of replicate samples, food matrix
diversity, and a clear decision-making process that considers the realistic variation that
occurs in testing. In a comparison of seven commercial gluten/wheat protein ELISA kits,
Rzychon et al. [25] demonstrated that the measured gluten contents in food samples varied
10–20 times between the kits and only four of the 24 analyzed samples were measured as
gluten-free by all seven of the kits. By spiking low to high levels of gluten and wheat flour
in a cornbread matrix, Sharma et al. [36] indicated wide-ranging recoveries tested with
the R-Biopharm AG, Morinaga, and Romer Labs kits. The authors also observed effects of
the gluten source, the spiking level, and the matrix, including baking time, on the gluten
determination.
3.2. Effect of Grain Sources on the Gluten and Wheat Proteins Contents
The gluten-free definition in the U.S. recognizes multiple grain sources of gluten.
However, the ability of the existing ELISA kits to detect and quantify differing glutens from
different grain sources has not widely been assessed. Thus, we moved forward to test a
number of grains with the four kits (Table 3).
Even though we attempted to homogenize samples, there were apparent high variations in the results for replicate samples using the same kit in a number of samples. The
results reflected subsampling differences. Nevertheless, adequate recoveries were obtained
from the four kits in most samples. As expected, the two R5 kits, utilizing the R5 antibody
that was raised against rye secalin extract [18], quantified higher apparent gluten contents
for the rye and triticale samples when compared to the common wheat samples on a total
weight basis. The results suggested that these cereal grains contain different numbers of
highly homologous gluten proteins with identical or highly similar copies of the epitopes
recognized by the antibodies as also previously observed by Ribeiro et al. [37]. In rye,
triticale, and barley there are a higher number of epitopes recognized by the R5 antibody
than in wheat [38]. In contrast, the epitopes recognized by the G12 antibody, which was
developed against the 33 amino acid α-gliadin peptide present in common wheat [34],
appears to be equivalently present in the extracts of common wheat, spelt, rye, and triticale
(Table 3). The epitopes recognizable by the R5 and the G12 antibodies are likely to be
present in higher amounts in the extracts derived from the hexaploid wheats than in those
from the tetraploid and diploid wheat varieties. However, club wheat, a hexaploid wheat,
tested comparatively low for apparent gluten content (Table 3), a result that is predictable
because club wheat has been known for its low gluten content [39]. The differences noted
between the grain samples in this study suggest the evolution of polyploidies that contain
multiple copies of genetically diverse proteins. By comparing five sandwich ELISA kits
(the R5, G12, Skerritt, pAb1, and pAb2), Lexhaller et al. [30] confirmed high variation in
antibody recognition among prolamins and glutelins from wheat, barley, and rye sources.
In addition, we found that the R-Biopharm AG kit and the G12 kit detected higher levels of
apparent gluten content in barley than in the common wheat confirming earlier observations by Pahlavan et al. [40]. The G12 kit exhibited some reactivity, all below 20 ppm, to the
four oat samples. Interestingly, the two R5 kits yielded apparently distinct levels of apparent gluten content in several samples including rye, barley, common wheat, club wheat, all
the tetraploid wheats, and the crude wheat gluten. The higher gluten levels obtained by
the R-Biopharm AG kit in those nine samples are, in part, possibly the consequence of the
pretreatment with the cocktail solution containing a protein unfolding agent and a protein
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disaggregating agent prior to the ethanol extraction (Table 1). Similar to our finding, in a
three-subsampling analysis of high gluten-containing commercial samples by Yu et al. [41],
the R-Biopharm AG kit yielded higher results when compared to the Neogen kit, nearly two
times higher for two wheat flours and 3.9, 4.6, and 5.6 times higher for instant noodle, udon,
and spaghetti, respectively. Apart from the three kits, the Morinaga kit yielded comparable
wheat protein contents in the samples of rye, triticale, barley, spelt, common wheat, all the
tetraploid wheats, and the crude wheat protein (Table 3). Overall, when compared across
the wheat samples, the club wheat and the einkorn wheat were detected at lower ppm
gluten and wheat protein on a total weight basis. Lower test results from these ELISAs
does not necessarily mean that the samples contain lesser amounts of the target protein(s).
Moreover, this does not guarantee that the two samples present significantly lower risks
to consumers with CeD. Several explanations are possible including that the two specific
species contain less gluten, as known in the case of club wheat, or that they express distinct
glutens that may not be extracted or detected equally by the specific antibodies. Even
within a single wheat species, distinct cultivars had been demonstrated to have different
gluten proteins [37]. As reported by Gianfrani et al. [42], two lines of einkorn wheat were
similar in their capacity to stimulate T-cell restricted interferon-γ (IFN-γ) secretion, but
only one line was reported to induce crypt hyperplasia.
The masking or interfering effect of food matrices was demonstrated when the crude
wheat gluten was spiked into three distinct raw matrices: sugar, oat flours, and sorghum
flour. The four kits adequately measure the expected levels of crude wheat gluten in the
sugar and four oat matrices (Table 3). However different results were obtained with the
four kits in the sorghum matrix. The averaged results were 8.55 ppm by the Morinaga kit,
67.5 ppm by the R-Biopharm AG kit, 247 ppm by the Romer Labs kit, and 653 ppm, the
most relevant result to the spiking level, by the Neogen kit. Since the variations in these kits
are low, the heterogeneity of the spiked sample and subsampling effects are less likely. One
possibility could be that the Macia variety of sorghum contains small but sufficient tannin to
interfere with the extraction via tannin–protein interactions [43]. Proteins in sorghum have
also been found to interfere with protein extraction via protein–protein interaction [44]. The
results obtained from the Neogen kit suggest the success in incorporating the extraction
additive to aid in extraction of the samples containing tannins/phenol compounds.
Taken together, all these kits have the capability to detect gluten proteins from all of
the gluten-containing grains, but the quantitative differences are due to several factors. The
two R5 kits utilize the same antibody that targets rye secalin but is also able to detect other
closely related prolamins and glutelins from other grains. The two R5 kits use different
gliadin standards and extraction schemes. There is a defect in normalizing glutens equally
as each of these grains represent mixtures including variable amounts of prolamin and
glutelin fractions [33]. Using reversed-phase high-performance liquid chromatography
(RP-HPLC), Wieser and Koehler [45] demonstrated that for common wheat, the prolamin
to glutelin ratio ranged from 1.5 to 3.1. The ratios ranged from 0.2 to 4.9 in commercial
wheat starches, at 1.4 to 5 for barley, at 6.3 to 8.2 for rye, and at 4.9 to 13.9 for einkorn
wheat. The ELISA kits applying the factor of 2 to adjust the results from gliadin to gluten
are therefore likely to underestimate or overestimate gluten content in some grains and
products. The G12 kit bases its quantification on a gluten standard calibrated to the PWG
gliadin, the varying ratios of prolamin to glutelin in various gluten-containing grains thus
would lead to misestimation. On the other hand, although the specificities of the polyclonal
antibodies and the calibration standard used in the Morinaga kit are unknown to us, our
findings indicated that the wheat proteins/related proteins in wheats, barley, and rye
measured by the kit are relatively close. In summary, differences in gluten protein type,
form and proportion, and differences in the content of interfering substances led to different
results determined by each of the ELISA kits. Furthermore, based on varied constructed
parameters, different results were obtained for the cereal grains using the four ELISA kits.
The source of the gluten proteins and the degree of hazard to the sensitive individuals
could not be ascertained without clinical studies. Nevertheless, the results were reasonably
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comparable between the four kits on most samples. The use of any of the four kits can
provide data to support the conformance of gluten-free products with regulatory labeling
requirements. In addition, our analysis using real-world food samples demonstrated
appropriate sensitivity obtained from the four kits to measure the gluten contents in typical
serving sizes of foods as previously investigated by Holzhauser et al. [46]. One drawback
of the ELISA kits however is that the sample sizes are very small compared to the typical
serving sizes, so subsample variability affects the reliability of results especially when
particulate contamination is encountered.
4. Conclusions
To date no analytical method exists that can precisely measure glutens from different grain sources, forms, and food matrices. Our gluten analyses in real food products,
ingredients, and raw grains indicated that the four sandwich ELISA platforms are not fully
comparable but are capable and suitable in detecting and quantifying gluten proteins in
various food samples. The four kits yield comparable results and could be used interchangeably in many food matrices. The suitability of each kit should be carefully considered
before using the kit to verify the gluten content in a food. The users should also be aware
that food can be heterogeneous and large sample and sampling sizes might help overcome
the uncertainty in divergent results obtained from the kit(s). Our findings demonstrate
that some variability within and between methods can be expected at gluten levels around
20 ppm. Thus, food companies making the gluten-free claims should select target levels
well below 20 ppm to assure compliance. Finally, we agree that the AOAC-validated R5
Méndez method is an appropriate choice to detect and measure gluten proteins at the level
of 20 ppm in various types and forms of food. We judge that any method that provides
comparable results to the R5 Méndez method is also suitable for gluten analysis and could
be used to document their suitability for the use to comply with the gluten-free definition.
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